NSEGeneral Updates3d ago · 18 Sept 2026, 06:18 pm
General Updates
Religare Enterprises Limited · RELIGARE
✦ AI SummaryFundraise
Religare Enterprises Limited has informed the Exchange about General Updates, specifically that its material subsidiary, Care Health Insurance Limited, has allotted 10,000 debentures worth Rs. 100 Crore at a coupon rate of 10% p.a. These debentures will be listed on the Debt Segment of National Stock Exchange of India Limited from September 22, 2026.
Analysis Scores
Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Religare Enterprises Limited has informed the Exchange about General Updates
Attachments (1)
📄pdf
Download →
RELIGARE_18092026181658_RELUPDATE06082026_CHIL.pdf
View document text
September 18, 2026
The National Stock Exchange of India Ltd. BSE Limited
Corporate Communications Department Corporate Services Department
“Exchange Plaza”, 5th Floor, Phiroze Jeejeebhoy Towers
Bandra-Kurla Complex, Bandra (East), Dalal Street,
Mumbai – 400051 Mumbai – 400001
Scrip Symbol: RELIGARE Scrip Code: 532915
Subject: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015
Dear Sir(s),
With reference to the captioned subject, we would like to inform you that Care Health Insurance Limited
(“CHIL”), a material subsidiary of Religare Enterprises Limited (“the Company”), has allotted 10,000 (Ten
Thousand) Debentures (unsecured, subordinated, listed, taxable, rated, redeemable, non-cumulative, non-
convertible debentures in the nature of ‘Subordinated Debt’ at a coupon rate fixed at 10.00% p.a.) each
bearing a face value of Rs. 1,00,000 (Rupees One Lakh) aggregating to Rs. 100 Crore (Rupees One Hundred
Crore), for cash, at par, in dematerialized form. Please see Annexure A for the details of the Debentures issued
by the CHIL.
Further, the aforesaid Debentures will be listed on Debt Segment of National Stock Exchange of India Limited
w.e.f. September 22, 2026.
This is for your kind information and record.
Thanking You
For Religare Enterprises Limited
Babu Rao P.
Group General Counsel & Group Chief Compliance Officer
Religare Enterprises Limited
CIN: L74899DL1984PLC146935
Registered Office: First Floor, Office No. 101, 2E/23, Jhandewalan Extn., New Delhi – 110055 Phone No.: +91-11- 4167 9692
Corporate Office: 1st Floor, Tower A, Club 125, Plot A-3,4, 5, Sector -125, Noida – 201301, Uttar Pradesh Phone No.: +91-120- 4384 941
www.religare.com / investorservices@religare.com
Annexure A
Sr. No. Particulars Remarks
1. Issuer Care Health Insurance Limited
2. Type of securities Listed, unsecured, subordinated, rated, redeemable, taxable, non-
proposed to be issued cumulative, non-convertible debentures in the nature of ‘Subordinated
Debt’ in accordance with the “IRDAI Laws and SEBI NCS Regulations. The
Debentures shall be fully paid up in cash.
3. Type of issuance Non-convertible debentures in the nature of subordinated debt
instruments, on a private placement basis
4. Size of issue Rs. 100,00,00,000 (Rupees One Hundred Crore).
5. Whether proposed to be Yes. National Stock Exchange of India Limited
listed? If yes, name of the
stock exchange(s)
6. Tenure of the instrument Tenor: 10 (Ten) years from the deemed date of allotment, subject to the
– date of allotment and exercise of any call option by the Company at the end of 5 (Five) years
date of maturity and every year thereafter.
Date of allotment: 18 September, 2026
Date of maturity: 18 September, 2036, subject to exercise of any Call
Option by the Company.
7. Coupon / interest offered, Coupon Rate: 10% per annum
schedule of payment
coupon/interest and Schedule of payment of interest and principal:
principal
The Debentures shall be redeemed at par 10 (Ten) years from the deemed
date of allotment, on 18 September, 2036, subject to the exercise of any
call option by the Company at the end of 5 (Five) years and every year
thereafter.
The Debentures shall carry interest in accordance with the term sheet as
set out in the key information document dated 17 September, 2026, on the
outstanding principal amount of Debentures until the redemption date.
The following terms and conditions shall be applicable in relation to any
Interest payment to be made by the Issuer pursuant to this Issue: (i) the
Interest or Default Interest (if applicable) on the Debentures shall be
charged to the profit and loss account of the Issuer, and will be paid
annually; (ii) the Issuer shall not be liable to pay the Interest or any
Default Interest (if applicable) for that financial year, if the payment of
such Interest is prohibited in terms of IRDAI Laws; (iii) prior approval of
IRDAI shall be required for payment of Interest or any Default Interest (as
applicable) for any financial year, if: (a) the impact of accrual or payment
of Interest or any Default Interest (as applicable) may result in net loss or
increase in the net loss of the Issuer;
(b) solvency margin of the Issuer is below the Control Level of Solvency;
or (c) the impact of such accruing or paying such Interest or Default
Interest (if applicable) would result in the Control Level of Solvency of the
Issuer falling below or remaining below the regulatory requirements
prescribed by the IRDAI; (iv) any Interest or Default Interest shall not be
cumulative i.e., the Interest missed in a year will not be paid in the future
years. The Issuer is permitted (but not obliged) to cumulate Interest
Religare Enterprises Limited
CIN: L74899DL1984PLC146935
Registered Office: First Floor, Office No. 101, 2E/23, Jhandewalan Extn., New Delhi – 110055 Phone No.: +91-11- 4167 9692
Corporate Office: 1st Floor, Tower A, Club 125, Plot A-3,4, 5, Sector -125, Noida – 201301, Uttar Pradesh Phone No.: +91-120- 4384 941
www.religare.com / investorservices@religare.com
which is not paid on an Interest Payment Date, and pay such Interest on a
subsequent Interest Payment Date compounded on an Actual/Actual basis
and in compliance with all Applicable Laws (including but not limited to
IRDAI Laws). It is hereby explicitly clarified that any cancellation of
servicing of the Debentures or non-payment of Interest or Default Interest
(if applicable), or the payment of any Interest in the subsequent financial
years by the Issuer, in the manner set out hereinabove shall not be
construed to be an Event of Default or be construed to be a breach of the
Transaction Documents of any manner and no restriction or obligation on
the Issuer of any kind whatsoever, including any obligation to pay Default
Interest, shall be imposed or be deemed to have been imposed on the
Issuer upon the occurrence of such an event except that the Issuer shall
not distribute any dividend to its equity shareholders. Payment of Interest
or Default Interest (if applicable) shall be subject to IRDAI Laws at all
times.
The calling of an Event of Default on account of, any event of non-payment
of Interest or Default Interest (if applicable), of the Debentures by the
Issuer shall be subject to the IRDAI Laws on the date of calling of the said
Event of Default.
8. Charge / security, if any, Not applicable
created over the assets
9. Special right/ interest/ Not applicable
privileges attached to the
instrument and changes
thereof
10. Delay in payment of Not applicable
interest/ principal amount
for a period of more than
three months from the
due date or default in
payment of interest/
principal
11. Details of any letter or Not applicable
comments regarding
payment / non-payment
of interest, principal on
due dates, or any other
matter concerning the
security and/ or the assets
along with its comments
thereon, if any
12. Details of redemption of Not applicable
preference shares
indicating the manner of
redemption (whether out
of profits or out of fresh
issue) and debentures
13. Any cancellation or Not applicable
termination of proposal
for issuance of securities
including reasons thereof.
Religare Enterprises Limited
CIN: L74899DL1984PLC146935
Registered Office: First Floor, Office No. 101, 2E/23, Jhandewalan Extn., New Delhi – 110055 Phone No.: +91-11- 4167 9692
Corporate Office: 1st Floor, Tower A, Club 125, Plot A-3,4, 5, Sector -125, Noida – 201301, Uttar Pradesh Phone No.: +91-120- 4384 941
www.religare.com / investorservices@religare.com